about
Age-associated oxidative damage leads to absence of gamma-cystathionase in over 50% of rat lenses: relevance in cataractogenesisOrdered transcriptional factor recruitment and epigenetic regulation of tnf-alpha in necrotizing acute pancreatitisObese rats exhibit high levels of fat necrosis and isoprostanes in taurocholate-induced acute pancreatitis.Lung myofibroblasts are characterized by down-regulated cyclooxygenase-2 and its main metabolite, prostaglandin E2.Role of cytokines and oxidative stress in the pathophysiology of acute pancreatitis: therapeutical implications.Angiotensinogen gene G-6A polymorphism influences idiopathic pulmonary fibrosis disease progression.Interaction between cytokines and oxidative stress in acute pancreatitis.Mitochondrial function in liver disease.Telomerase and telomere length in pulmonary fibrosis.Redox signaling and histone acetylation in acute pancreatitis.Oxidative and nitrosative stress in acute pancreatitis. Modulation by pentoxifylline and oxypurinol.Pentoxifylline prevents loss of PP2A phosphatase activity and recruitment of histone acetyltransferases to proinflammatory genes in acute pancreatitis.RNAPol-ChIP: a novel application of chromatin immunoprecipitation to the analysis of real-time gene transcription.Disulfide stress: a novel type of oxidative stress in acute pancreatitis.Ursodeoxycholic acid protects against secondary biliary cirrhosis in rats by preventing mitochondrial oxidative stress.Circulating TNF-alpha and its soluble receptors during experimental acute pancreatitis.Effect of simultaneous inhibition of TNF-alpha production and xanthine oxidase in experimental acute pancreatitis: the role of mitogen activated protein kinases.Low prostaglandin E2 and cyclooxygenase expression in nasal mucosa fibroblasts of aspirin-intolerant asthmatics.Glutamate cysteine ligase up-regulation fails in necrotizing pancreatitis.The activation of ERK1/2 MAP kinases in glioblastoma pathobiology and its relationship with EGFR amplification.Reduced expression of COXs and production of prostaglandin E2 in patients with nasal polyps with or without aspirin-intolerant asthma[Experimental models for the study of pulmonary fibrosis: current usefulness and future promise]
P50
Q28305098-A6054C5B-5EBC-4892-9180-BED06119D936Q28564232-0C644209-F96C-4E48-9BC1-017132EDD271Q34427069-7D0B644F-CF5C-4A94-ADB9-B5D083192A46Q34766530-7A07363B-FCFE-4EE1-B499-B8B806EB3E09Q35560593-1C09B7DF-CED0-44AE-82B7-253B4245D0DFQ35663920-E08DD626-207B-412D-850B-3AC690047042Q36638600-F179EAEC-E63D-439E-9D8A-04AD5234FEDFQ36664551-9A0FA83F-F7BE-4B10-BDCC-100D8E1992D6Q37297921-AE43535D-E5A1-4F0F-8C6A-A546AB6BCFA4Q37969542-833F163D-21DA-429A-8775-D221CE6B300AQ39457846-FD84077A-36C0-4E8D-AF15-6AA14422D98FQ39813749-95DB0840-3156-459A-8CDA-547100FA2D03Q41023269-DBF6BC5B-C25E-4E46-BD1E-4C123E973399Q42453002-F4F77C96-1B80-4278-8886-A002ADCB92EEQ44785865-89C60FA5-5C69-4BA4-BD98-42EBF0CA150EQ44911734-83302674-53AC-495B-92CC-1D8CEC813E25Q44949299-EE6C67B4-63B6-479E-BF8B-8B5CDC5E4936Q46240727-36A61CC8-31A7-489A-BFC1-BD1FB316EC9AQ46750254-C5F4BCAB-B327-4F6B-A887-DA064378D72EQ55466683-B3D84AF2-8D56-43C7-8143-36F455413B55Q62520456-99732A61-167B-47DB-92EC-FECE713BD0B3Q81403395-7A76BC74-7CF7-4A4D-A5FC-665E63BE176F
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Javier Pereda
@ast
Javier Pereda
@en
Javier Pereda
@es
Javier Pereda
@nl
Javier Pereda
@sl
type
label
Javier Pereda
@ast
Javier Pereda
@en
Javier Pereda
@es
Javier Pereda
@nl
Javier Pereda
@sl
prefLabel
Javier Pereda
@ast
Javier Pereda
@en
Javier Pereda
@es
Javier Pereda
@nl
Javier Pereda
@sl
P106
P21
P31
P496
0000-0002-8690-8938